Stefania Livia Ciummo - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Stefania Livia Ciummo

Showing results (1-10 of 12) with videos related to

Pageof 2

Sort By:

Journal of Experimental & Clinical Cancer Research : CR|December 13, 2023

Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathwaysStefania Livia Ciummo, Carlo Sorrentino, Cristiano Fieni, et al.

Medcomm|October 22, 2024

Nanomedicine for cancer patient-centered careCarlo Sorrentino, Stefania Livia Ciummo, Cristiano Fieni, et al.

Frontiers in Immunology|January 3, 2022

Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall SurvivalCarlo Sorrentino, Luigi D'Antonio, Cristiano Fieni, et al.

Molecular Biomedicine|June 24, 2026

Prostatic fibroblast reprogramming by Interleukin-30 activates prostate cancer metastasis programsStefania Livia Ciummo, Carlo Sorrentino, Simona Marchetti, et al.

Journal for Immunotherapy of Cancer|March 17, 2023

Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survivalLuigi D'Antonio, Cristiano Fieni, Stefania Livia Ciummo, et al.

Frontiers in Cell and Developmental Biology|July 1, 2021

The C-X-C Motif Chemokine Ligand 1 Sustains Breast Cancer Stem Cell Self-Renewal and Promotes Tumor Progression and Immune Escape ProgramsStefania Livia Ciummo, Luigi D'Antonio, Carlo Sorrentino, et al.

Journal for Immunotherapy of Cancer|October 19, 2021

Interleukin-30 feeds breast cancer stem cells via CXCL10 and IL23 autocrine loops and shapes immune contexture and host outcomeCarlo Sorrentino, Stefania Livia Ciummo, Luigi D'Antonio, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2024

Prevention of prostate cancer metastasis by a CRISPR-delivering nanoplatform for interleukin-30 genome editingCristiano Fieni, Stefania Livia Ciummo, Carlo Sorrentino, et al.

Clinical and Translational Medicine|February 26, 2021

Hindering triple negative breast cancer progression by targeting endogenous interleukin-30 requires IFNγ signalingCarlo Sorrentino, Stefania Livia Ciummo, Luigi D'Antonio, et al.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 7, 2026

Interleukin-30 promotes melanoma spreading and triggers LAG-3 expression and T cell exhaustionSimona Marchetti, Carlo Sorrentino, Cristiano Fieni, et al.

Pageof 2

Search research articles

Showing results (1-10 of 12) with videos related to

Sort By:

Pageof 2

Journal of Experimental & Clinical Cancer Research : CR|December 13, 2023

Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathwaysStefania Livia Ciummo, Carlo Sorrentino, Cristiano Fieni, et al.

Medcomm|October 22, 2024

Nanomedicine for cancer patient-centered careCarlo Sorrentino, Stefania Livia Ciummo, Cristiano Fieni, et al.

Frontiers in Immunology|January 3, 2022

Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall SurvivalCarlo Sorrentino, Luigi D'Antonio, Cristiano Fieni, et al.

Molecular Biomedicine|June 24, 2026

Prostatic fibroblast reprogramming by Interleukin-30 activates prostate cancer metastasis programsStefania Livia Ciummo, Carlo Sorrentino, Simona Marchetti, et al.

Journal for Immunotherapy of Cancer|March 17, 2023

Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survivalLuigi D'Antonio, Cristiano Fieni, Stefania Livia Ciummo, et al.

Frontiers in Cell and Developmental Biology|July 1, 2021

The C-X-C Motif Chemokine Ligand 1 Sustains Breast Cancer Stem Cell Self-Renewal and Promotes Tumor Progression and Immune Escape ProgramsStefania Livia Ciummo, Luigi D'Antonio, Carlo Sorrentino, et al.

Journal for Immunotherapy of Cancer|October 19, 2021

Interleukin-30 feeds breast cancer stem cells via CXCL10 and IL23 autocrine loops and shapes immune contexture and host outcomeCarlo Sorrentino, Stefania Livia Ciummo, Luigi D'Antonio, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2024

Prevention of prostate cancer metastasis by a CRISPR-delivering nanoplatform for interleukin-30 genome editingCristiano Fieni, Stefania Livia Ciummo, Carlo Sorrentino, et al.

Clinical and Translational Medicine|February 26, 2021

Hindering triple negative breast cancer progression by targeting endogenous interleukin-30 requires IFNγ signalingCarlo Sorrentino, Stefania Livia Ciummo, Luigi D'Antonio, et al.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 7, 2026

Interleukin-30 promotes melanoma spreading and triggers LAG-3 expression and T cell exhaustionSimona Marchetti, Carlo Sorrentino, Cristiano Fieni, et al.

Pageof 2